TP53 and neoplasm: TP53 mutations are well-characterized for their impact on the regulation of tumor failsafe mechanisms [65,66,67], metabolism [68], and immune cell infiltration [69] and are detected in more than 70% of PDAC specimens, particularly in poorly differentiated basal-like PDAC subtypes [17].